Related Experiment Videos
Nonimmune hydrops fetalis
1Division of Maternal-Fetal Medicine, Women & Infants' Hospital of Rhode Island, Providence, USA.
The Journal of Perinatal & Neonatal Nursing
|May 20, 2000
Summary
Nonimmune hydrops fetalis (NIHF) is a serious condition characterized by fetal edema from various causes. While some cases are treatable with intrauterine therapies, the overall prognosis remains poor, emphasizing the need for comprehensive prenatal and delivery room care.
Area of Science:
- Perinatology
- Fetal Medicine
- Neonatology
Background:
- Nonimmune hydrops fetalis (NIHF) describes fetal edema unrelated to isoimmunization.
- Causes are diverse, including diseases, structural anomalies, and genetic abnormalities.
- NIHF presence is a poor prognostic indicator, even when the cause is unknown.
Purpose of the Study:
- To review the causes, diagnostic challenges, and management strategies for nonimmune hydrops fetalis.
- To highlight the importance of prenatal diagnosis and intrauterine therapies.
- To emphasize the critical role of specialized delivery room management for affected infants.
Main Methods:
- Literature review of causes, diagnosis, and treatment of NIHF.
- Discussion of prenatal testing and intrauterine interventions.
- Outline of delivery room resuscitation protocols for NIHF infants.
Main Results:
- NIHF has a wide range of etiologies, often associated with poor outcomes.
- Intrauterine therapies like cordocentesis and fetal surgery offer potential treatment options.
- Prenatal diagnosis and management are complex, expensive, and stressful for families.
Conclusions:
- Early diagnosis and intervention are crucial for improving outcomes in NIHF.
- Comprehensive patient and family support is essential throughout the prenatal period.
- Specialized resuscitation plans are vital for maximizing survival in neonates with NIHF.